Wellnex Life Limited

WNX · AIM · Retail · mcap £4.0m · 5.5p

Beta Briefing, track record and bull & bear case are not ready for Wellnex Life Limited yet.

We follow 817 UK small caps and every one of their announcements – often hundreds per company. 41 companies are already wired into a briefing: browse them.

All announcements Monitoring checked today, 11:05

All · 31 Key · 27

Date	Type	Announcement	Day
05 Oct 26	Director dealing	Director’s dealing Wellnex Life Limited (ASX/AIM: WNX) ("Wellnex Life" or the "Company") has been notified by Jeffrey Yeh, non-executive director of Wellnex Life, that on 30 September 2026 entities of which Mr Yeh is the ultimate beneficia	+0.0%
11 Sep 26		Completion and Settlement of Sale of Pain Away Completion and Settlement of Sale of Pain Away	+0.0%
08 Sep 26		Results of Meeting Wellnex Life Limited (ASX/AIM: WNX) ("Wellnex Life" or the "Company") advises in accordance with ASX Listing Rule 3.13.2 and section 251AA of the Corporations Act 2001 (Cth), details of the results and proxies received i	+0.0%
01 Sep 26	Board change	Change of Chief Financial Officer Wellnex Life Limited (ASX/AIM: WNX) ("Wellnex Life" or the "Company") advises that Ms Vivienne Zhang will step down from her role as Chief Financial Officer ("CFO"), with Mr Joe Rinarelli appointed as the Company's new C	+0.0%
01 Sep 26	Results	Annual Report for Year Ended 30 June 2026 Audited FY26 Annual Report - Significant Improvement in Financial Performance	+0.0%
07 Aug 26	Routine	Posting of EGM Notice and Explanatory Memorandum
06 Aug 26		Sale of Pain Away for up to A$21.3 million Sale of Pain Away for up to A$21.3 million	+69.2%
31 Jul 26		Q4 FY26 Quarterly Update and Appendix 4C Quarterly Update and Appendix 4C - June 2026	+0.0%
12 Jun 26	Board change	Appointment of Non-Executive Director Wellnex Life Limited (ASX/AIM: WNX) ("Wellnex Life" or the "Company") is pleased to announce that Hilton Wood has been appointed to the Board as an independent Non-Executive Director of Wellnex Life, effective immediatel	+0.0%
30 Apr 26		Q3 FY26 Quarterly Update and Appendix 4C Quarterly Update and Appendix 4C - March 2026	+0.0%
23 Apr 26		Extension of Loan Repayment Wellnex Life Limited (ASX/AIM: WNX) ("Wellnex Life" or the "Company") announces an extension to the previously announced repayment of the loans to former directors totalling circa $2.88 million (including interest), whic	+0.0%
21 Apr 26		Update on loan repayment Wellnex Life Limited (ASX/AIM: WNX) ("Wellnex Life" or the "Company") announces an update to the previously announced repayment of the loans to former directors totalling $2.88m (including interest), which were due for r	+0.0%
07 Apr 26	Holding	Holding(s) in Company
02 Apr 26		Extension of Haleon Licensing and Supply Agreement Wellnex Life Limited (ASX/AIM: WNX) ("Wellnex Life" or the "Company") is pleased to announce that the Company, through its wholly owned subsidiary BSPS Aust Pty Ltd, has signed an extension to the existing licensing and	+0.0%
27 Mar 26		Issue of Shares Wellnex Life Limited (ASX/AIM: WNX) ("Wellnex Life" or the "Company") announces that it is has agreed full and final settlement with former corporate advisors regarding outstanding fees relating to past corporate advisor	−10.5%
12 Mar 26	Board change	Directorate Change Wellnex Life Limited (ASX/AIM: WNX) ("Wellnex Life" or the "Company") is pleased to announce that Eric Jiang, currently Non-Executive Director of Wellnex Life, has been appointed by the Board as Interim Executive Chair,	+0.0%
27 Feb 26		Half Yearly Report and Accounts ● Significant improvements in H1 FY26 as revenue increased 8% to $12.9 million	+0.0%
09 Feb 26		Company Update Wellnex Life Limited (ASX/AIM: WNX) ("Wellnex Life" or the "Company")	+0.0%
29 Jan 26		Q2 FY26 Quarterly Update and Appendix 4C · Operating cash outflow improved significantly to $(0.16)m, from $(2.98) m in Q1 FY26 on the back of 31.5% QoQ revenue growth and significant cost reductions	+0.0%
16 Jan 26		Market Update Wellnex Life Limited (ASX/AIM:WNX) ("Wellnex Life" or the "Company") announces that Executive Chairman, Ash Vesali, is today providing the following update to shareholders, ahead of the Company's unaudited results for th	+13.3%
15 Jan 26	Director dealing	Director/PDMR Shareholding
16 Dec 25	Trading update	Trading Update Wellnex Life Limited (ASX/AIM:WNX) ("Wellnex Life" or the "Company") announces that Executive Chairman, Ash Vesali, has today provided the following update to shareholders.	+0.0%
27 Nov 25	Board change	Results of AGM and Board Change All resolutions set out in the Notice of AGM and Explanatory Memorandum dated 28 October 2025, were duly carried by poll, including resolution 14 which was passed as a special resolution by a sufficient majority, save fo	+0.0%
27 Nov 25		Withdrawal of Resolution & Resignation of Director Update on Loan repayment, Withdrawal of AGM Resolution and Board Change	+0.0%
27 Nov 25	Board change	Chair AGM Speech Wellnex Life Limited (ASX/AIM:WNX) ("Wellnex Life" or the "Company") announces that Executive Chairman, Ash Vesali, is today providing the following update to shareholders during company's annual general meeting.	+0.0%
10 Nov 25		Update on Loan Repayment This ASX/AIM announcement has been authorised by the Board of Wellnex Life Limited (ASX/AIM:WNX).	+0.0%
03 Nov 25		Update on Loan Repayment A further update will be issued once the repayment schedule is finalised.	+0.0%
28 Oct 25	Routine	Notice of AGM
21 Oct 25	Board change	Resignation of CEO and Loan Repayment The Board of Wellnex Life Limited (ASX/AIM: WNX) (Wellnex Life or Company) announces that Mr.	−3.8%
20 Oct 25		Q1 FY26 Quarterly Report and Appendix 4C Wellnex Life Limited (ASX/AIM: WNX) ("Wellnex Life" or the "Company") is pleased to provide the following operational and business update along with its Appendix 4C for the quarter ended 30 September 2025 (unaudited).	−3.7%
20 Oct 25	Board change	Chairman’s letter - Shareholder Update Wellnex Life Limited (ASX/AIM:WNX) ("Wellnex Life" or the "Company") announces that Executive Chairman, Ash Vesali, is today providing the following update to shareholders, and has separately announced the Company's Q1 F	−3.7%

Company filings. Not investment advice.